Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-052846
Filing Date
2013-10-07
Accepted
2013-10-07 14:07:13
Documents
1
Period of Report
2013-10-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd392307.html 4  
1 FORM 4 rrd392307.xml 4 57704
  Complete submission text file 0001181431-13-052846.txt   59075
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Nashat Amir (Reporting) CIK: 0001575843 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36076 | Film No.: 131138758